Literature DB >> 9563950

Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.

A V Philips1, L T Timchenko, T A Cooper.   

Abstract

Myotonic dystrophy (DM) is caused by a CTG expansion in the 3' untranslated region of the DM gene. One model of DM pathogenesis suggests that RNAs from the expanded allele create a gain-of-function mutation by the inappropriate binding of proteins to the CUG repeats. Data presented here indicate that the conserved heterogeneous nuclear ribonucleoprotein, CUG-binding protein (CUG-BP), may mediate the trans-dominant effect of the RNA. CUG-BP was found to bind to the human cardiac troponin T (cTNT) pre-messenger RNA and regulate its alternative splicing. Splicing of cTNT was disrupted in DM striated muscle and in normal cells expressing transcripts that contain CUG repeats. Altered expression of genes regulated posttranscriptionally by CUG-BP therefore may contribute to DM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563950     DOI: 10.1126/science.280.5364.737

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  334 in total

1.  EMBO Workshop Report: Molecular genetics of muscle development and neuromuscular diseases Kloster Irsee, Germany, September 26-October 1, 1999.

Authors:  T Brand; G Butler-Browne; E M Füchtbauer; R Renkawitz-Pohl; B Brand-Saberi
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

Review 3.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

Review 4.  Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Authors:  R P Junghans; A Ebralidze; B Tiwari
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

5.  Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing.

Authors:  M Brudno; M S Gelfand; S Spengler; M Zorn; I Dubchak; J G Conboy
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

6.  SRp30c is a repressor of 3' splice site utilization.

Authors:  Martin J Simard; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation.

Authors:  G Raca; E Y Siyanova; C T McMurray; S M Mirkin
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

8.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

9.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

10.  Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.

Authors:  Natalia Gromak; Arianne J Matlin; Thomas A Cooper; Christopher W J Smith
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.